BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34475782)

  • 1. Upregulation of
    Zhang X; Huang T; Li Y; Qiu H
    Int J Gen Med; 2021; 14():4945-4957. PubMed ID: 34475782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 3. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer.
    Lu Y; Kong X; Zhong W; Hu M; Li C
    Front Mol Biosci; 2021; 8():647095. PubMed ID: 33996903
    [No Abstract]   [Full Text] [Related]  

  • 5. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
    Wang D; Jiao Z; Ji Y; Zhang S
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
    Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
    Front Oncol; 2020; 10():553297. PubMed ID: 33614473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
    Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
    Front Genet; 2021; 12():796592. PubMed ID: 35126464
    [No Abstract]   [Full Text] [Related]  

  • 9. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
    Cheng A; Guo X; Dai X; Wang Z
    FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLEC4E upregulation in gastric cancer: A potential therapeutic target correlating with tumor-associated macrophages.
    Jiang Q; Xiao D; Wang A; Yu Q; Yin Y; Wu J; Zhang Y; Jin T; Kuang B; Jia Y
    Heliyon; 2024 Mar; 10(5):e27172. PubMed ID: 38463883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 12. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
    Zheng H; Liu H; Li H; Dou W; Wang X
    Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent manner.
    Xu J; Yu Y; He X; Niu N; Li X; Zhang R; Hu J; Ma J; Yu X; Sun Y; Ni H; Wang F
    Am J Transl Res; 2019; 11(9):6040-6054. PubMed ID: 31632572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
    Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
    J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.